New baby formula aims to mimic breast Milk's gut benefits

NCT ID NCT06361719

Recruiting now Disease control Sponsor: Société des Produits Nestlé (SPN) Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether a starter infant formula with added human milk oligosaccharides (2'FL and LNnT) can improve gut health and immune development in healthy Chinese infants. About 262 babies will be randomly assigned to receive either the special formula or a standard formula, with a breastfed group as reference. The trial runs until the babies are 12 months old, measuring gut bacteria and other health markers.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Infant formula with added human milk oligosaccharides (2'FL and LNnT)
What this could lead to: If successful, this could show that adding these HMOs to formula helps support gut health and immune development in formula-fed infants, similar to breastfed babies.
What could go wrong: This is an early-stage study in healthy infants, so results may not apply to other populations. The benefits may be small or not clinically meaningful.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEALTHY INFANTS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HEALTHY INFANTS

Contacts and locations

Locations

The International Peace Maternity & Child Health Hospital of China Welfare Institute
RECRUITING

Shanghai, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.